抗发作药物与突触囊泡蛋白2A (SV2A) 结合的基因调节机制
Anshumali Mittal1, Matthew F Martin1, Laurent Provins2
1Department of Structural Biology, University of Pittsburgh, Pittsburgh, PA 15213.
抗发作药物与突触囊泡蛋白2A (SV2A) 的结合性增强. 这一发现揭示了一个新的结合点和网络,为新的SV2A向治疗铺平了道路.
科学领域:
- 神经科学
- 结构生物学
- 药理学
背景情况:
- 突触囊泡蛋白2A (SV2A) 是抗发作药物 (ASM) 的关键标,如布里瓦拉 (BRV) 和莱维维拉 (LEV).
- 了解与SV2A结合的ASM的结构基础对于开发更有效的治疗至关重要.
研究的目的:
- 阐明UCB1244283通过基调节SV2A结合的结构机制.
- 识别和描述SV2A上的新结合点.
主要方法:
- 用X射线结晶学测定SV2A与各种配体 (BRV,UCB-J,UCB7361,UCB1244283) 的结构.
- 针对位点的突变发生,以调查特定残留物在连接物中的作用.
- 生物化学测定以评估结合性和选择性.
主要成果:
- UCB1244283与SV2A上的新位结合,增强了BRV和LEV的结合.
- 连接初级和初级位点的异质网络控制着高亲缘关系的ASM结合.
- 对于SV2A,UCB1244283比SV2B和SV2C具有选择性.
- 主要部位的联结会影响跨膜域的构造,影响全部位的可访问性.
结论:
- 已确定的全位和网络为治疗提供了新的途径.
- 向这种全位可能导致新型SV2A调节剂的开发,其疗效和选择性得到改善.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
10:19Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes
Published on: January 10, 2011
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
